MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

29 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 3109.90 millions, about 23.17% up against Rs. 2524.80 millions recorded during the year-ago period.A comparatively good net profit growth of 31.40% to Rs. 611.80 millions was reported for the quarter ended March 2025 compared to Rs. 465.60 millions of previous same quarter.Operating profit surged to 840.30 millions from the corresponding previous quarter of 697.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202406 202306 % Var
Sales 3109.90 2524.80 23.17 9341.70 8673.80 7.70 11512.60 12296.20 -6.37
Other Income 31.10 22.70 37.00 103.50 135.00 -23.33 156.30 183.90 -15.01
PBIDT 840.30 697.10 20.54 3287.40 2712.50 21.19 3216.30 3430.70 -6.25
Interest 1.30 1.50 -13.33 4.30 5.20 -17.31 7.20 7.70 -6.49
PBDT 839.00 695.60 20.62 3283.10 2707.30 21.27 3007.20 3423.00 -12.15
Depreciation 53.70 68.40 -21.49 166.90 202.40 -17.54 274.00 281.00 -2.49
PBT 785.30 627.20 25.21 3116.20 2504.90 24.40 2733.20 3142.00 -13.01
TAX 173.50 161.60 7.36 772.10 662.90 16.47 723.40 847.30 -14.62
Deferred Tax -33.60 -1.40 2300.00 -4.90 -18.60 -73.66 -86.00 -50.60 69.96
PAT 611.80 465.60 31.40 2344.10 1842.00 27.26 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.02 27.61 -2.14 35.19 31.27 12.53 27.94 27.90 0.13
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..